Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.


Journal Article

Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, high-risk GTN, and intermediate trophoblastic tumor.

Full Text

Duke Authors

Cited Authors

  • Abu-Rustum, NR; Yashar, CM; Bean, S; Bradley, K; Campos, SM; Chon, HS; Chu, C; Cohn, D; Crispens, MA; Damast, S; Dorigo, O; Eifel, PJ; Fisher, CM; Frederick, P; Gaffney, DK; Han, E; Huh, WK; Lurain, JR; Mariani, A; Mutch, D; Nagel, C; Nekhlyudov, L; Fader, AN; Remmenga, SW; Reynolds, RK; Sisodia, R; Tillmanns, T; Ueda, S; Wyse, E; McMillian, NR; Scavone, J

Published Date

  • November 1, 2019

Published In

Volume / Issue

  • 17 / 11

Start / End Page

  • 1374 - 1391

PubMed ID

  • 31693991

Pubmed Central ID

  • 31693991

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2019.0053


  • eng

Conference Location

  • United States